Novel Immunotherapy Approaches Targeting TIGIT: Updates and Perspectives for the Oncology Care Team

Download All
Gain insight into the emerging role of TIGIT as a target for immunotherapy and learn about therapies in development through expert commentaries, podcasts, a text-based module, and a downloadable slideset.
person default
Ani Balmanoukian, MD
person default
Diwakar Davar, MD
person default
Jyoti D. Patel, MD

Podcasts

Listen to Drs. Jyoti Patel and Diwakar Davar as they discuss the latest research on TIGIT, the exciting emerging target in immune checkpoint inhibitors.

person default Diwakar Davar, MD person default Jyoti D. Patel, MD Released: April 7, 2022

Listen to Dr. Jyoti D. Patel and Dr. Ani Balmanoukian as they discuss the potential role of anti-TIGIT therapies in lung cancer and other solid malignancies.

person default Ani Balmanoukian, MD person default Jyoti D. Patel, MD Released: April 15, 2022

Text Module

Diwakar Davar, MD, and Jyoti D. Patel, MD, discuss the role of and rationale for targeting TIGIT, as well as current data and emerging therapies.

person default Diwakar Davar, MD person default Jyoti D. Patel, MD Physicians: maximum of 1.0 AMA PRA Category 1 Credit Registered Nurses: 1.0 Nursing contact hour Pharmacists: 1.0 contact hour (0.1 CEUs) Released: April 27, 2022 Expired: April 26, 2023

Diwakar Davar, MD, and Jyoti D. Patel, MD, review TIGIT as an emerging target, as well as available data on investigational therapies targeting TIGIT.

person default Diwakar Davar, MD person default Jyoti D. Patel, MD Released: April 27, 2022

ClinicalThought

In this commentary, Diwakar Davar, MD, and Jyoti D. Patel, MD, review TIGIT as a therapeutic target and discuss data from key clinical trials, including the TIGIT inhibitor tiragolumab in NSCLC.

person default Diwakar Davar, MD person default Jyoti D. Patel, MD Released: April 14, 2022

In this commentary, Ani Balmanoukian, MD, and Jyoti D. Patel, MD, discuss emerging data with and the potential role of anti-TIGIT therapy in lung cancer and other solid tumors.

person default Ani Balmanoukian, MD person default Jyoti D. Patel, MD Released: May 3, 2022
Provided by Clinical Care Options, LLC.

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by an educational grant from
Genentech, a member of the Roche Group

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings